ArcelorMittal to Take Full Ownership of Leading Argentinian Steel Company

ArcelorMittal, the world's largest steel company, announces today the results of its cash tender offer to acquire the 35.5% of outstanding shares in Acindar Industria Argentina de Aceros S.A. it does not currently own (the "Offering").

ArcelorMittal announces today that Acindar's cash tender offer has achieved 98.6% participation for 35.5% of the outstanding shares of Acindar. As of the expiration date, the Offering has been accepted for an aggregate amount of 336 class A shares and 303.327.703 class B shares of Acindar, all issued and outstanding, representing 35.0% of the capital stock of such company. On the February 14, the closing date, ArcelorMittal will pay to the shareholders the amount of USD 552 million for the tendered shares.

As a consequence, adding the abovementioned percentage to the 64.5% interest in Acindar held by ArcelorMittal through ArcelorMittal Brasil S.A. as of January 31, 2008, ArcelorMittal shall become the holder of 99.5% of Acindar's capital stock.

Commenting, Lakshmi N. Mittal, President and CEO, ArcelorMittal said:

"I am very pleased that we have received such a positive response from shareholders to our offer. Acindar, as part of the ArcelorMittal Group, will have additional opportunities to benefit from being part of the world's leading steel company. We are very committed to our business in Argentina and Latin America and will continue to look for opportunities to further enhance the profile and performance of our assets in this region."

Since no resolutory condition to which the effectiveness of the Offering was subject has occurred as of today, the Offering was declared to be effective and ArcelorMittal will proceed to acquire all the shares tendered by the shareholders accepting the Offering and pay the offered price in the manner and conditions provided for in the Prospectus.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.